Susquehanna International Group
EIGR

Susquehanna International Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Susquehanna International Group’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-517
Closed -$13.9K – 13471
2023
Q1 		$13.9K Sell
517
-386
-43% -$18K ﹤0.01% 12139
2022
Q4 		$32K Sell
903
-2,117
-70% -$254K ﹤0.01% 11602
2022
Q3 		$682K Buy
3,020
+1,487
+97% +$366K ﹤0.01% 7641
2022
Q2 		$290K Sell
1,533
-2,734
-64% -$551K ﹤0.01% 9650
2022
Q1 		$1.06M Buy
4,267
+2,387
+127% +$377K ﹤0.01% 6958
2021
Q4 		$293K Sell
1,880
-763
-29% -$148K ﹤0.01% 10555
2021
Q3 		$530K Sell
2,643
-5,427
-67% -$1.29M ﹤0.01% 9238
2021
Q2 		$2.06M Buy
8,070
+13
+0.2% +$3.24K ﹤0.01% 5851
2021
Q1 		$2.14M Sell
8,057
-156
-2% -$49.2K ﹤0.01% 5766
2020
Q4 		$3.03M Buy
8,213
+5,633
+218% +$1.62M ﹤0.01% 4297
2020
Q3 		$630K Buy
+2,580
New +$803K ﹤0.01% 7189
2020
Q1 		– Sell
-633
Closed -$283K – 11057
2019
Q4 		$283K Buy
+633
New +$225K ﹤0.01% 8145
2015
Q4 		– Sell
-39
Closed -$18K – 10105
2015
Q3 		$18K Sell
39
-75
-66% -$39.8K ﹤0.01% 9509
2015
Q2 		$65K Sell
114
-532
-82% -$1.47M ﹤0.01% 9816
2015
Q1 		$5.5M Buy
+646
New +$5.65M ﹤0.01% 2607

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Susquehanna International Group's EIGR Position: Q1 2024 in Review

Susquehanna International Group sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2024, closing a stake of 850 shares — an estimated $5.73K sold.

Susquehanna International Group first reported a position in EIGR in Q4 2014 and held it in 22 quarters. The position peaked at $1.27M in Q1 2019. 24 funds tracked by Wall St. Rank hold EIGR as of Q1 2024.

  • Susquehanna International Group reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 850 Eiger BioPharmaceuticals, Inc. shares in Q1 2024, an estimated $5.73K.
  • Susquehanna International Group first reported a position in Eiger BioPharmaceuticals, Inc. in Q4 2014 and held it in 22 quarters.
  • Susquehanna International Group's Eiger BioPharmaceuticals, Inc. position peaked at $1.27M in Q1 2019.
  • 24 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.